Managers

Blockchain Capital collects $150 mln for fourth fund

San Francisco-based Blockchain Capital, a venture firm focused on the blockchain technology sector and crypto ecosystem, has raised $150 million for its fourth fund. Blockchain Capital IV's limited partners include fund of funds, foundations, strategic investors and family offices. In conjunction with the fundraising, Blockchain has promoted Spencer Bogart from managing director and head of research to partner.

Healthcare tech BioIQ snags $26.5 mln

Santa Barbara, California-based BioIQ, a healthcare technology, has raised $26.5 million in funding. HealthQuest Capital led the round with participation from other investors that included Arboretum Ventures.

Sequoia raising up to $12 bln in growth, other funds: CNBC

Sequoia Capital is raising as much as $12 billion between its global growth fund and other venture-capital and growth funds in the United States and China, according to a report by CNBC.

Qiming to raise $900 mln sixth venture fund

Qiming Venture Partners has set out to raise a $900 million sixth venture fund, according to a filing with the SEC.

Khosla Ventures to raise $400 mln fourth seed fund

Khosla Ventures has set out to raise a $400 million fourth seed fund, according to a filing with the SEC.

Amity Ventures amasses over $48 mln for $300 mln-targeted fund

San Francisco-based Amity Ventures has raised over $48 million for its new fund, according to an SEC filing. The target is $300 million.

DOJ, SEC push back against claim that U.S. securities laws are vague as applied to ICOs

Omidyar Networks spin-out Spero Ventures raises $100 mln for maiden fund

Spero Ventures, a spin-out of Omidyar Network, a philanthropic investment firm funded by eBay co-founder Pierre Omidyar, has launched and raised $100 million for its debut fund, according to a blog post by Shripriya Mahesh, the new venture firm's founding partner. The fund's investor is Omidyar.

TCR2 Therapeutics hauls in $125 mln Series B

Cambridge, Massachusetts-based TCR2 Therapeutics Inc, an immuno-oncology company, has raised $125 million in Series B funding. The lead investors were 6 Dimensions Capital and Curative Ventures. Other investors in the round included Redmile Group, ArrowMark Partners, Hillhouse Capital Group, MiraeAsset Financial Group, Lucion Group, Sirona Capital, Alexandria Venture Investments, MPM Capital, F2 Ventures and Cathay Fortune Capital Investment.

Cernostics lands $2.5 mln

Pennsylvania-based Cernostics, a provider of next-generation cancer diagnostics and prognostics, has raised $2.5 million in Series A1 financing. Illumina Ventures led the round.